Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8655655,Arrd2,Age-related retinal degeneration QTL 2,7.79,,retinal layer morphology trait (VT:0003727),percentage of study population developing retinopathy during a period of time (CMO:0002453),1,183970203,243914901,Rat,n/a,region,qtl 1000,8655855,Arrd3,Age-related retinal degeneration QTL 3,3.07,,lens clarity trait (VT:0001304),cataract incidence/prevalence measurement (CMO:0001585),1,183970203,243914901,Rat,n/a,region,qtl 1000,2300175,Bmd40,Bone mineral density QTL 40,15.4,0.0001,femur mineral mass (VT:0010011),bone mineral density (CMO:0001226),1,201554356,246554356,Rat,n/a,region,qtl 1000,2300187,Bmd41,Bone mineral density QTL 41,8.9,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),1,171629477,216629477,Rat,n/a,region,qtl 1000,2300174,Bmd42,Bone mineral density QTL 42,8.4,0.0001,lumbar vertebra mineral mass (VT:0010511),bone mineral density (CMO:0001226),1,171629477,216629477,Rat,n/a,region,qtl 1000,2300161,Bmd43,Bone mineral density QTL 43,8.4,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),1,171629477,216629477,Rat,n/a,region,qtl 1000,634312,Bp143,Blood pressure QTL 143,3,0.0002,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,182623426,219932796,Rat,n/a,region,qtl 1000,731168,Bp154,Blood pressure QTL 154,3.4,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,94642722,214537671,Rat,n/a,region,qtl 1000,737977,Bp160,Blood pressure QTL 160,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,181133855,226133855,Rat,n/a,region,qtl 1000,1300168,Bp170,Blood pressure QTL 170,2.76,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,207702246,228581766,Rat,n/a,region,qtl 1000,1331790,Bp201,Blood pressure QTL 201,3.127,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,198211513,225126682,Rat,n/a,region,qtl 1000,1354606,Bp246,Blood pressure QTL 246,3.6,,arterial blood pressure trait (VT:2000000),pulse pressure (CMO:0000292),1,102813953,218753816,Rat,n/a,region,qtl 1000,1358898,Bp255,Blood pressure QTL 255,3.6,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,191019702,246062233,Rat,n/a,region,qtl 1000,1358890,Bp259,Blood pressure QTL 259,3.06,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,210702053,260522016,Rat,n/a,region,qtl 1000,61341,Bp26,Blood pressure QTL 26,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,169537671,214537671,Rat,n/a,region,qtl 1000,1358886,Bp260,Blood pressure QTL 260,3.67,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,151162766,225824951,Rat,n/a,region,qtl 1000,2292220,Bp306,Blood pressure QTL 306,3.47,0.00087,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,164310393,243914901,Rat,n/a,region,qtl 1000,7421630,Bp362,Blood pressure QTL 362,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,118608292,241799120,Rat,n/a,region,qtl 1000,10059600,Bp378,Blood pressure QTL 378,3.08,0.05,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,176869060,221869060,Rat,n/a,region,qtl 1000,61376,Bp42,Blood pressure QTL 42,23.4,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,197814409,242814409,Rat,n/a,region,qtl 1000,1549830,Bss1,Bone structure and strength QTL 1,4.8,,femur strength trait (VT:0010010),femur ultimate force (CMO:0001675),1,172609619,217609619,Rat,n/a,region,qtl 1000,2293693,Bss22,Bone structure and strength QTL 22,33.52,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),1,171629477,216629477,Rat,n/a,region,qtl 1000,2293673,Bss27,Bone structure and strength QTL 27,18.63,0.0001,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),1,171629477,216629477,Rat,n/a,region,qtl 1000,2293654,Bss30,Bone structure and strength QTL 30,32.65,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),1,171629477,216629477,Rat,n/a,region,qtl 1000,2293655,Bss36,Bone structure and strength QTL 36,10.66,0.0001,femur strength trait (VT:0010010),femur ultimate force (CMO:0001675),1,201554356,246554356,Rat,n/a,region,qtl 1000,2293694,Bss38,Bone structure and strength QTL 38,7.05,0.0001,femur strength trait (VT:0010010),femur stiffness (CMO:0001674),1,201554356,246554356,Rat,n/a,region,qtl 1000,2293674,Bss39,Bone structure and strength QTL 39,7.1,0.0001,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),1,201554356,246554356,Rat,n/a,region,qtl 1000,2293677,Bss41,Bone structure and strength QTL 41,9.38,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra cross-sectional area (CMO:0001689),1,171629477,216629477,Rat,n/a,region,qtl 1000,2293689,Bss47,Bone structure and strength QTL 47,7.25,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra trabecular cross-sectional area (CMO:0001692),1,171629477,216629477,Rat,n/a,region,qtl 1000,10059587,Bw173,Body weight QTL 173,3.23,0.025,body mass (VT:0001259),body weight (CMO:0000012),1,202069611,247069611,Rat,n/a,region,qtl 1000,70163,Bw20,Body weight QTL 20,5.1,,body mass (VT:0001259),body weight (CMO:0000012),1,174133260,219133260,Rat,n/a,region,qtl 1000,1354661,Bw33,Body weight QTL 33,5.2,,body mass (VT:0001259),body weight (CMO:0000012),1,151162512,256448636,Rat,n/a,region,qtl 1000,1354610,Bw34,Body weight QTL 34,4.1,,body mass (VT:0001259),body weight (CMO:0000012),1,151162512,256448636,Rat,n/a,region,qtl 1000,1358294,Bw37,Body weight QTL 37,5,0.000011,body mass (VT:0001259),body weight (CMO:0000012),1,171310381,216310381,Rat,n/a,region,qtl 1000,1357335,Bw39,Body weight QTL 39,3.3,,body mass (VT:0001259),body weight (CMO:0000012),1,197814409,242814409,Rat,n/a,region,qtl 1000,1357404,Bw42,Body weight QTL 42,4.49,0.0001,body mass (VT:0001259),body weight (CMO:0000012),1,206329708,251329708,Rat,n/a,region,qtl 1000,1357399,Bw45,Body weight QTL 45,3.05,,body mass (VT:0001259),body mass index (BMI) (CMO:0000105),1,206329708,251329708,Rat,n/a,region,qtl 1000,1558658,Bw59,Body weight QTL 59,3.5,0.0003,body mass (VT:0001259),body weight (CMO:0000012),1,178784622,223784622,Rat,n/a,region,qtl 1000,631214,Bw61,Body weight QTL61,3.4,0.0001,intramuscular adipose amount (VT:0010044),intramuscular fat area (CMO:0001162),1,173108781,218108781,Rat,n/a,region,qtl 1000,2292216,Bw80,Body weight QTL 80,3.23,0.0019,body mass (VT:0001259),body weight (CMO:0000012),1,213533809,243914901,Rat,n/a,region,qtl 1000,2302375,Bw83,Body weight QTL 83,4.87,0.0002,body mass (VT:0001259),body weight (CMO:0000012),1,197697768,242697768,Rat,n/a,region,qtl 1000,1354624,Cm35,Cardiac mass QTL35,5.7,,heart left ventricle mass (VT:0007031),calculated heart weight (CMO:0000073),1,177227632,256448636,Rat,n/a,region,qtl 1000,1358292,Cm37,Cardiac mass QTL 37,6.2,0.00000081,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),1,196248093,241248093,Rat,n/a,region,qtl 1000,1578780,Cm52,Cardiac mass QTL 52,3.3,0.0001,heart mass (VT:0007028),heart wet weight (CMO:0000069),1,81591954,219808434,Rat,n/a,region,qtl 1000,631658,Cm7,Cardiac mass QTL 7,5.32,0.0001,aorta mass (VT:0002845),aorta weight (CMO:0000076),1,196248093,241248093,Rat,n/a,region,qtl 1000,7771612,Cm80,Cardiac mass QTL 80,8.4,,heart left ventricle mass (VT:0007031),heart left ventricle weight (CMO:0000776),1,149448574,221264292,Rat,n/a,region,qtl 1000,1600397,Edcs4,Endometrial carcinoma susceptibility QTL 4,2.2,,uterus morphology trait (VT:0001120),percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759),1,206081677,251081677,Rat,n/a,region,qtl 1000,8552891,Epfw5,Epididymal fat weight QTL 5,4.4,,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),1,193113876,238113876,Rat,n/a,region,qtl 1000,1358191,Ept10,Estrogen-induced pituitary tumorigenesis QTL 10,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),1,192825253,243914732,Rat,n/a,region,qtl 1000,2312564,Glom18,Glomerulus QTL 18,2.4,0.003,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),1,185356336,231689108,Rat,n/a,region,qtl 1000,634321,Hc1,Hypercalciuria QTL 1,2.91,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),1,178810256,240830002,Rat,n/a,region,qtl 1000,1600363,Hc6,Hypercalciuria QTL 6,2.7,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),1,203995416,244113296,Rat,n/a,region,qtl 1000,1549837,Hcar15,Hepatocarcinoma resistance QTL 15,,0.05,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,153136852,260522016,Rat,n/a,region,qtl 1000,634338,Hcar4,Hepatocarcinoma resistance QTL 4,4.6,,liver integrity trait (VT:0010547),liver tumorous lesion number to liver area ratio (CMO:0001210),1,193422268,214537671,Rat,n/a,region,qtl 1000,634340,Hcar5,Hepatocarcinoma resistance QTL 5,8,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,214537555,226660468,Rat,n/a,region,qtl 1000,737828,Hcas3,Hepatocarcinoma susceptibility QTL 3,4.9,,liver integrity trait (VT:0010547),liver tumorous lesion volume to total liver volume ratio (CMO:0001082),1,144267353,222987745,Rat,n/a,region,qtl 1000,738032,Hcas5,Hepatocarcinoma susceptibility QTL 5,3.12,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,176426412,257976495,Rat,n/a,region,qtl 1000,2293083,Iddm25,Insulin dependent diabetes mellitus QTL 25,4.18,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,181829673,224569684,Rat,n/a,region,qtl 1000,2302378,Insul11,Insulin level QTL 11,3.25,,blood insulin amount (VT:0001560),serum insulin level (CMO:0000358),1,144267353,251128347,Rat,n/a,region,qtl 1000,724538,Kidm1,Kidney mass QTL 1,3.2,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),1,213707201,252085212,Rat,n/a,region,qtl 1000,1354646,Kidm18,Kidney mass QTL 18,5.7,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),1,151162512,256448636,Rat,n/a,region,qtl 1000,1354652,Kidm20,Kidney mass QTL 20,4.3,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),1,177227632,256448636,Rat,n/a,region,qtl 1000,1358916,Kidm22,Kidney mass QTL 22,3.32,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),1,210702053,240947965,Rat,n/a,region,qtl 1000,1578763,Kidm29,Kidney mass QTL 29,3.3,0.0001,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),1,179567751,260522016,Rat,n/a,region,qtl 1000,1582206,Kidm33,Kidney mass QTL 33,6.9,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),1,188377360,224054420,Rat,n/a,region,qtl 1000,2292218,Kidm35,Kidney mass QTL 35,,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),1,199368955,224569684,Rat,n/a,region,qtl 1000,10059590,Kidm44,Kidney mass QTL 44,3.42,0.025,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),1,191033875,236033875,Rat,n/a,region,qtl 1000,1600374,Mcs17,Mammary carcinoma susceptibility QTL 17,3,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),1,197670404,242670404,Rat,n/a,region,qtl 1000,7794788,Mcs32,Mammary carcinoma susceptibility QTL 32,2.61,,mammary gland integrity trait (VT:0010552),mammary tumor incidence/prevalence measurement (CMO:0000946),1,115540693,238914717,Rat,n/a,region,qtl 1000,631838,Niddm36,Non-insulin dependent diabetes mellitus QTL 36,,0.01,insulin secretion trait (VT:0003564),calculated pancreatic islet insulin release measurement (CMO:0001217),1,184550676,229550676,Rat,n/a,region,qtl 1000,61403,Niddm4,Non-insulin dependent diabetes mellitus QTL 4,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),1,206329708,222745518,Rat,n/a,region,qtl 1000,634313,Niddm43,Non-insulin dependent diabetes mellitus QTL 43,,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,199050459,259647894,Rat,n/a,region,qtl 1000,734768,Niddm59,Non-insulin dependent diabetes mellitus QTL 59,,,body mass (VT:0001259),body weight (CMO:0000012),1,213843987,258843987,Rat,n/a,region,qtl 1000,1600388,Niddm67,Non-insulin dependent diabetes mellitus QTL 67,5.84,0.000004,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),1,195804352,257091168,Rat,n/a,region,qtl 1000,1600396,Niddm68,Non-insulin dependent diabetes mellitus QTL 68,4.97,0.0003,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),1,195804352,257091168,Rat,n/a,region,qtl 1000,1600395,Niddm69,Non-insulin dependent diabetes mellitus QTL 69,4.14,0.0002,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),1,195804352,257091168,Rat,n/a,region,qtl 1000,61455,Niddm7,Non-insulin dependent diabetes mellitus QTL 7,5.5,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),1,214537555,238757011,Rat,n/a,region,qtl 1000,1600380,Niddm70,Non-insulin dependent diabetes mellitus QTL 70,3.1,0.0008,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),1,176550523,221550523,Rat,n/a,region,qtl 1000,724559,Pancm1,Pancreatic morphology QTL 1,7.1,,islet of Langerhans morphology trait (VT:0005215),pancreatic islet damage composite score (CMO:0001156),1,181759564,214537555,Rat,n/a,region,qtl 1000,2312420,Pur17,Proteinuria QTL 17,7.1,0.0001,urine protein amount (VT:0005160),urine total protein excretion rate (CMO:0000756),1,156677124,218753816,Rat,n/a,region,qtl 1000,1578778,Pur4,Proteinuria QTL 4,3.3,0.003,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),1,150700247,252085048,Rat,n/a,region,qtl 1000,724562,Rends1,Renal damage susceptibility QTL 1,,0.05,kidney glomerulus integrity trait (VT:0010546),index of glomerular damage (CMO:0001135),1,169537671,214537671,Rat,n/a,region,qtl 1000,1300145,Rf7,Renal function QTL 7,2.96,,urine creatinine amount (VT:0010540),urine creatinine level (CMO:0000125),1,185145134,221264292,Rat,n/a,region,qtl 1000,6903303,Scl34,Serum cholesterol QTL 34,2.5,0.0033,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),1,180359209,218108781,Rat,n/a,region,qtl 1000,1354580,Scort1,Serum corticosterone level QTL 1,3.4,,blood corticosterone amount (VT:0005345),blood corticosterone level (CMO:0001172),1,156677124,256448636,Rat,n/a,region,qtl 1000,1641926,Teswt2,Testicular weight QTL 2,2.82,,testis mass (VT:1000644),both testes wet weight (CMO:0000175),1,197697768,238755659,Rat,n/a,region,qtl 1000,1298084,Thym4,Thymus enlargement QTL 4,10.68,,thymus mass (VT:0004954),thymus weight to body weight ratio (CMO:0000612),1,197814409,242814409,Rat,n/a,region,qtl 1000,1578759,Uae30,Urinary albumin excretion QTL 30,3.3,0.003,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),1,150700247,252085048,Rat,n/a,region,qtl 1000,7394701,Uae46,Urinary albumin excretion QTL 46,3.6,0.0056,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),1,201554356,246554356,Rat,n/a,region,qtl 1000,724531,Uae5,Urinary albumin excretion QTL 5,4,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),1,150700142,252085212,Rat,n/a,region,qtl